When it comes to commercialisation of pharmaceutical products, a joint mindset of business strategy and regulatory affairs will benefit your case from early phase development, through launch and all the way to geographical expansion.
Convincing authorities, payers and other stakeholders about your product’s value requires both global knowledge and local expertise. Arex can help you build a business case that conveys the opportunities for all parties involved.
Arex will support your medicinal product commercialisation, without time-consuming detours. Our experts manage regulatory risks and identify regulatory opportunities. You can expect complexity to turn into clarity.
Our approach combines expertise in regulatory affairs and operations with our specialist skills in strategic business development for pharma.
The Arex team is experienced in life science entrepreneurship, with a joint perspective of scientific focus and commercial strategy. With this specialised expertise, we can facilitate strategic decision making for successful organisations and business management in pharma and biotech.
Navigating the regulatory landscape is challenging. Evaluating needs for resources in distribution, Market Access, Pharmacovigilance etc. requires specialised intelligence for each function. We support management teams with advice for efficient and successful organisational structures.
For each unique business case we define the organisational set-up based on which competences are needed to succeed and which competences are obsolete. The result is a cost-efficient organisation, fit for purpose.
Our longstanding experience in the life science industry includes entrepreneurship, business expansion strategies, M&A, partnership negotiations and investor relations. We know how to use regulatory affairs to unlock business opportunities.
With a holistic approach to life science business, we offer a set of strategic services to ensure both compliance and competitiveness. We offer a specialised team, providing their niche expertise in due diligence, Market Access, Quality Assurance, Good Distribution Practice (GDP) and more.
We analyse and mitigate risks related to commercial contracts in pharma and biotech and fuel your taskforce with knowledge to make your business case stronger:
With Arex as your Contract Pharma Organisation, your profits are free to grow alongside your product in the new market.
Lovisa Rosenquist
Arex Advisor AB
Contact us
Staffan Thunell
Founding partner
BSc Economics and BA
Staffan has a long background in entrepreneurship within the life science industry. He has 20+ years experience from positions as Founder, Chairman, CEO and CFO within medical affairs consulting and small pharma. Previously Staffan worked in executive positions in big pharma and specialty pharma companies.